The China Mail - Who should get paid for nature's sequenced genes?

USD -
AED 3.672504
AFN 68.211665
ALL 83.532896
AMD 383.502854
ANG 1.789699
AOA 917.000367
ARS 1324.570877
AUD 1.532567
AWG 1.8025
AZN 1.70397
BAM 1.678726
BBD 2.016566
BDT 121.342432
BGN 1.678755
BHD 0.374147
BIF 2978.069611
BMD 1
BND 1.283464
BOB 6.900991
BRL 5.431804
BSD 0.998755
BTN 87.452899
BWP 13.43805
BYN 3.297455
BYR 19600
BZD 2.00618
CAD 1.37545
CDF 2890.000362
CHF 0.809575
CLF 0.024733
CLP 970.26737
CNY 7.181504
CNH 7.189125
COP 4044.890777
CRC 506.072701
CUC 1
CUP 26.5
CVE 94.644007
CZK 20.983604
DJF 177.846444
DKK 6.411504
DOP 60.99309
DZD 128.915497
EGP 48.172181
ERN 15
ETB 138.586069
EUR 0.858504
FJD 2.252304
FKP 0.743884
GBP 0.744574
GEL 2.703861
GGP 0.743884
GHS 10.536887
GIP 0.743884
GMD 72.503851
GNF 8660.572508
GTQ 7.66319
GYD 208.952405
HKD 7.84995
HNL 26.151667
HRK 6.47204
HTG 130.681087
HUF 339.580388
IDR 16256.1
ILS 3.430695
IMP 0.743884
INR 87.72425
IQD 1308.355865
IRR 42125.000352
ISK 122.830386
JEP 0.743884
JMD 159.9073
JOD 0.70904
JPY 147.641504
KES 128.990172
KGS 87.450384
KHR 4000.686666
KMF 422.150384
KPW 900.008192
KRW 1388.770383
KWD 0.30553
KYD 0.832325
KZT 539.727909
LAK 21608.514656
LBP 89486.545642
LKR 300.373375
LRD 200.248916
LSL 17.702931
LTL 2.95274
LVL 0.60489
LYD 5.415218
MAD 9.044505
MDL 16.768379
MGA 4407.536157
MKD 52.817476
MMK 2099.254958
MNT 3587.23202
MOP 8.075018
MRU 39.838634
MUR 45.410378
MVR 15.403739
MWK 1731.857002
MXN 18.579904
MYR 4.240377
MZN 63.960377
NAD 17.702931
NGN 1532.290377
NIO 36.753787
NOK 10.282604
NPR 139.924467
NZD 1.676587
OMR 0.381572
PAB 0.998755
PEN 3.535041
PGK 4.212695
PHP 56.750375
PKR 283.390756
PLN 3.64774
PYG 7480.36565
QAR 3.650401
RON 4.355304
RSD 100.553624
RUB 79.739067
RWF 1444.659028
SAR 3.752762
SBD 8.217066
SCR 14.720484
SDG 600.503676
SEK 9.578804
SGD 1.285404
SHP 0.785843
SLE 23.103667
SLL 20969.503947
SOS 570.790953
SRD 37.279038
STD 20697.981008
STN 21.02914
SVC 8.738681
SYP 13001.954565
SZL 17.696236
THB 32.325038
TJS 9.328183
TMT 3.51
TND 2.928973
TOP 2.342104
TRY 40.795038
TTD 6.779108
TWD 29.907104
TZS 2481.867731
UAH 41.31445
UGX 3563.795545
UYU 40.075533
UZS 12578.000944
VES 128.74775
VND 26225
VUV 118.521058
WST 2.657279
XAF 563.029055
XAG 0.026074
XAU 0.000294
XCD 2.70255
XCG 1.800009
XDR 0.700227
XOF 563.029055
XPF 102.364705
YER 240.450363
ZAR 17.75662
ZMK 9001.203584
ZMW 23.145788
ZWL 321.999592
  • RBGPF

    1.2400

    73.08

    +1.7%

  • RELX

    -1.0566

    48

    -2.2%

  • AZN

    -0.5050

    73.55

    -0.69%

  • RIO

    1.0900

    61.86

    +1.76%

  • BP

    -0.0500

    34.14

    -0.15%

  • GSK

    0.2200

    37.8

    +0.58%

  • RYCEF

    -0.0200

    14.42

    -0.14%

  • SCS

    -0.1200

    15.88

    -0.76%

  • SCU

    0.0000

    12.72

    0%

  • BTI

    0.5500

    57.24

    +0.96%

  • NGG

    -1.0700

    71.01

    -1.51%

  • BCC

    -1.1000

    82.09

    -1.34%

  • CMSC

    0.0900

    23.05

    +0.39%

  • CMSD

    0.0600

    23.58

    +0.25%

  • JRI

    0.0250

    13.435

    +0.19%

  • BCE

    0.5700

    24.35

    +2.34%

  • VOD

    0.1000

    11.36

    +0.88%

Who should get paid for nature's sequenced genes?
Who should get paid for nature's sequenced genes? / Photo: © AFP/File

Who should get paid for nature's sequenced genes?

Much of the vanilla that flavors our ice cream today is artificial, derived from the genetic signature of a plant that hundreds of years ago was known only to an Indigenous Mexican tribe.

Text size:

The plant's sequenced genomic information, available on public databases, was used as the basis for a synthetic flavoring that today competes with vanilla grown in several countries, mainly by small-scale farmers.

Few, if any, benefits of the lucrative scientific advance have trickled down to the communities that gave us vanilla in the first place.

"Wild genetic resources and pharmaceuticals ... are a multi-multi-billion dollar businesses. They clearly are profitable... that's not in dispute," Charles Barber of the World Resources Institute think tank told AFP.

"A great deal of really valuable information has fed into the system from research and utilization of wild genetic resources. And there is no mechanism currently to compensate the people where this information is coming from" in the form of digitally sequenced data, he added.

Much of the information comes from poor countries.

Fair sharing of the gains derived from digitally-stored genetic sequencing data has been a headache for negotiators at the COP16 biodiversity summit into its second week in Cali, Colombia.

At the last conference, in Montreal in 2022, 196 country parties to the UN's Convention on Biological Diversity (CBD) agreed to create a benefit-sharing mechanism for the use of digital sequence information (DSI).

Two years later, they still need to resolve such basic questions as who pays, how much, into which fund, and to whom does the money go?

- 'Cheap and very fast' -

The issue is a complex one.

There is little debate that genetic data-sharing on mostly free-access platforms is crucial for human advancement through medicine and vaccine development, for example.

But how to quantify the value of the sequenced information itself? And should the first people to discover a plant's particular usefulness be compensated?

"Sequencing technology has become so advanced that you can go with a... handheld device a little bit bigger than a cell phone and you can literally sequence a genome in an hour or two and upload it as you sequence it," Pierre du Plessis, a DSI expert and former negotiator for African countries at the CBD told AFP.

These gene sequences are then uploaded to databases which artificial intelligence can mine for potential leads for product development.

DSI is worth an estimated hundreds of billions of dollars a year. And there is a lot of it out there.

"Once the sequence is put into a public database, generally, no benefit-sharing obligations apply," Nithin Ramakrishnan, a researcher with the Third World Network, an advocacy NGO for developing countries, told AFP in Cali.

"Like when the sandalwood sequence information is available in the database whether India wants to share its sandalwood... with a cosmetic company or not, doesn't matter.

- Mandatory -

A point of contention in Cali is a demand from developing countries that payment for DSI use be mandatory, perhaps through a one-percent levy on profits from drugs, cosmetics or other products.

They also want guarantees of non-monetary benefits such as access to vaccines produced from genetic information sequenced from viruses and other pathogens.

"We want real understanding, sector-specific understanding of what non-monetary benefits will be shared and we want the system to be obligatory -- the users should have some form of obligation to share benefits," said Ramakrishnan.

Another sticking point is access for Indigenous people and local communities to DSI funds.

Developing countries want the information on genetic databases to be traceable and "answerable to governments" of the countries where it comes from, said Ramakrishnan.

But rich nations and many researchers oppose such a model which they fear will be too onerous, potentially putting the brakes on scientific pursuits that could benefit all humankind.

With such divergent points of view, observers are doubtful the Cali COP will emerge with any firm decisions on the outstanding questions by closing time on Friday.

The World Wildlife Fund has said "many more rounds of negotiations appear necessary" on DSI.

Added Barber: "I think it's not going to all get solved here."

Y.Su--ThChM